MabVax Therapeutics Presents Two Posters At The AACR Annual Meeting On A Novel Radioimmunotherapy Treatment For Pancreatic Cancer Post author:Sam Post published:April 4, 2017 Post category:BioPharma Life Sciences Jobs … Source: BioSpace You Might Also Like Celgene Takes a $411M Hit From Discontinuation of Crohn's Disease Trials December 28, 2017 Scientists Use Graphene To Power 'Electronic Skin' That Can Feel, University of Glasgow Study Reveals March 22, 2017 Tyme To Present Prostate Cancer Data From Its Ongoing Phase II Trial For SM-88 At August 28, 2017
Scientists Use Graphene To Power 'Electronic Skin' That Can Feel, University of Glasgow Study Reveals March 22, 2017